Christopher G. Hayes, CHIEF LEGAL OFFICER at Verrica Pharmaceuticals Inc. (VRCA), sold 43,389 shares at $7.06 ($306K) on 2024-07-22, disclosed to the SEC on 2024-07-23.
Open-market sale of $306k VRCA by CHIEF LEGAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.06 | 21,649 | $153K | 49.9% |
| 2 | $7.06 | 21,649 | $153K | 49.9% |
| 3 | $6.98 | 91 | $635 | 0.2% |
| Total | $7.06 avg | 43,389 | $306K | 100% |
| Filing → |
| VRCA | SELL | 2023-11-16 | $164K | — | Filing → |
| VRCA | SELL | 2023-07-25 | $326K | — | Filing → |
| VRCA | BUY | 2022-07-11 | $26K | — | Filing → |